Preemption Motion Withdrawn In NuvaRing MDL

Law360, New York (March 9, 2009, 12:00 AM EDT) -- Days after the U.S. Supreme Court's decision in Wyeth v. Levine, attorneys for Organon International Inc. in the multidistrict litigation over its NuvaRing contraceptive have withdrawn a motion that sought summary judgment on preemption grounds.

Counsel for Organon informed Judge Rodney W. Sippel of the U.S. District Court for the Eastern District of Missouri in a status conference on Thursday that the company intends to withdraw the motion with leave to refile as a result of the Wyeth decision. That ruling found that drug companies aren't...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.